🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,40 USD

Máx. histórico

119,27

4270 días

Caída desde máximo

-69,48%

Rango 52 semanas

18,80 – 36,67

Variación hoy

+0,03%

Cierre anterior

36,39

Rango de hoy

36,38 – 36,45

Volumen hoy

2.420.374

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
104,00 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 7 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/12/2015 78,39 78,97 77,32 77,87 -0,54% 2,10% 249.300
23/12/2015 76,44 79,35 75,37 78,29 +3,09% 5,21% 413.200
22/12/2015 73,96 77,48 73,51 75,94 +1,15% 5,37% 522.400
21/12/2015 77,06 77,39 72,36 75,08 -1,35% 6,53% 828.600
18/12/2015 73,20 77,50 72,87 76,11 +3,38% 6,33% 1.657.900
17/12/2015 73,43 73,74 71,81 73,62 +0,88% 2,63% 947.200
16/12/2015 71,67 73,60 70,56 72,98 +2,95% 4,24% 1.196.700
15/12/2015 70,95 75,00 69,13 70,89 +13,55% 8,27% 4.063.400
14/12/2015 61,84 63,29 61,28 62,43 +0,61% 3,25% 389.300
11/12/2015 62,93 63,90 61,83 62,05 -2,96% 3,29% 388.100
10/12/2015 63,36 64,69 63,36 63,94 +0,55% 2,10% 426.700
09/12/2015 62,76 64,38 62,01 63,59 +0,68% 3,78% 286.400
08/12/2015 61,58 64,24 60,70 63,16 +1,49% 5,75% 387.700
07/12/2015 64,66 64,66 61,72 62,23 -3,49% 4,55% 490.300
04/12/2015 63,67 64,64 63,02 64,48 +1,78% 2,54% 488.800
03/12/2015 63,43 64,33 61,82 63,35 +0,25% 3,96% 677.200
02/12/2015 66,63 67,36 62,67 63,19 -5,53% 7,04% 972.100
01/12/2015 65,00 67,85 63,63 66,89 +3,31% 6,49% 945.300
30/11/2015 65,36 65,36 62,83 64,75 -0,55% 3,87% 583.900
27/11/2015 65,20 65,53 63,89 65,11 +0,28% 2,52% 219.900
25/11/2015 61,76 65,37 61,50 64,93 +6,20% 6,27% 956.000
24/11/2015 60,72 61,50 59,48 61,14 -0,65% 3,33% 550.100
23/11/2015 60,20 62,84 60,02 61,54 +1,72% 4,68% 842.700
20/11/2015 59,10 60,65 57,69 60,50 +2,87% 5,01% 1.571.200
19/11/2015 57,97 59,49 57,23 58,81 +1,50% 3,90% 414.200
18/11/2015 56,81 58,73 56,35 57,94 +2,48% 4,19% 477.700
17/11/2015 55,97 58,00 55,23 56,54 +1,47% 4,95% 372.800
16/11/2015 56,15 56,80 54,53 55,72 -1,01% 4,04% 481.900
13/11/2015 54,74 58,70 54,14 56,29 +3,95% 8,33% 556.000
12/11/2015 53,29 55,98 53,13 54,15 -0,26% 5,35% 444.900